Reductions in prostatic doses are associated with less acute morbidity in patients undergoing Pd-103 brachytherapy: Substantiation of the rationale for focal therapy

Other literature type English OPEN
Ferro, Adam; Bae, Hee Joon; Yenokyan, Gayane; Le, Yi; McNutt, Todd; Mian, Omar; Gergis, Carol; Haviland, Chloe; DeWeese, Theodore L.; Song, Daniel Y.;

PURPOSE/OBJECTIVES: Interest in prostate dose reduction or focal treatment exists due to expected reductions in treatment morbidity. Prior analyses have not generally corroborated relationships between prostate or urethral dose and urinary toxicity after brachytherapy, ... View more
Share - Bookmark